MENU
+Compare
ARGNF
Stock ticker: OTC
AS OF
Jul 2 closing price
Price
$547.60
Change
+$0.42 (+0.08%)
Capitalization
35B

ARGNF Argen X NV Forecast, Technical & Fundamental Analysis

Argenx is a Dutch biopharmaceutical company focused on developing antibody-based therapies for rare autoimmune diseases... Show more

ARGNF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ARGNF with price predictions
Jul 21, 2025

ARGNF's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for ARGNF turned positive on July 14, 2025. Looking at past instances where ARGNF's MACD turned positive, the stock continued to rise in of 19 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 18 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The Momentum Indicator moved above the 0 level on July 15, 2025. You may want to consider a long position or call options on ARGNF as a result. In of 17 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

ARGNF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The 50-day moving average for ARGNF moved below the 200-day moving average on July 01, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.094) is normal, around the industry mean (18.131). P/E Ratio (33.390) is within average values for comparable stocks, (58.574). ARGNF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.444). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. P/S Ratio (14.164) is also within normal values, averaging (274.844).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. ARGNF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
ARGNF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Laarderhoogtweg 25
Phone
+31 107038441
Employees
1148
Web
https://www.argenx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KR72.020.63
+0.88%
Kroger Co (The)
VLY9.530.02
+0.21%
Valley National Bancorp
KVAC11.54N/A
N/A
Keen Vision Acquisition Corp
ALGT51.45-0.24
-0.46%
Allegiant Travel Company
BTM5.44-0.40
-6.85%
Bitcoin Depot

ARGNF and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ARGNF has been loosely correlated with SLS. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if ARGNF jumps, then SLS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARGNF
1D Price
Change %
ARGNF100%
N/A
SLS - ARGNF
36%
Loosely correlated
+4.52%
RLMD - ARGNF
31%
Poorly correlated
+6.41%
TPST - ARGNF
27%
Poorly correlated
+0.71%
GNNSF - ARGNF
23%
Poorly correlated
N/A
CVALF - ARGNF
23%
Poorly correlated
-1.58%
More